INCYTE CORPORATION Deferred Tax Assets, Deferred Income
INCYTE CORPORATION (INCY) had Deferred Tax Assets, Deferred Income of $20.33 million as of 2015-12-31, per its 10-K filed 2017-02-14.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2017-02-14
- 2015-12-31: Deferred Tax Assets, Deferred Income $20.33M.
- 2014-12-31: Deferred Tax Assets, Deferred Income $20.38M.
- 2013-12-31: Deferred Tax Assets, Deferred Income $8.00M.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2015-12-31 | $20.33M 10-K · filed 2017-02-14 |
| 2014-12-31 | $20.38M 10-K · filed 2016-02-12 |
| 2013-12-31 | $8.00M 10-K · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |